LUMAKRAS
Identification of Lumakras
| No description |
Google image searchProduct monograph
Active ingredient
sotorasib, 120 MG
DIN: 02520095
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: AMGEN CANADA INC
Date: 22-OCT-2021
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XX — Other antineoplastic agents (ATC, ATC/DDD)
- L01XX73 — SOTORASIB (ATC/DDD)
